Sponsors and CROs still face many of the same site activation and patient enrollment challenges across today's clinical studies. Traditional approaches have not only led…
With many clinical trials grinding to a halt weeks or months ago, the FDA’s updated…
While industry media are reporting that some clinical trials that had been paused are restarting,…
We recently spoke with Carl Cook, Vice President of Clinical Operations at Black Diamond Therapeutics,…
Recent events have struck at the very soul of our nation. They demand nothing less…
Your protocol has been amended. There’s been a key finding that requires a change in procedure.…
For months, public health experts have shared a constant refrain, stating that widespread testing and…
When discussing how they manage clinical trial staff, industry veterans have often told us that they get…
We have all witnessed the remarkable dedication of our first responders and healthcare workers as…
We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an…
We are all finding ways personally and professionally to meet the challenge posed by COVID-19. …
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based…
The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the…
As the coronavirus continues to spread and dominate the media, we are inundated with advice…
There are many ways a clinical trial can go wrong: There might be delays in site identification, initiation, or…
Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov Below image:…
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech…
See how the ArcheMedX Platform can transform your organization’s learning and insights